Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence
International Journal of Nanomedicine · 2026
DOI: 10.2147/ijn.s634276 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Kunpeng Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Sulfonamides, Leukemia, Myeloid, Acute, Liposomes, Bridged Bicyclo Compounds, Heterocyclic. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
- Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
ORCID-Profile: Kunpeng Luo
Zitieren
APA
Luo, K., Hui, Y., Shen, H., Yan, L., Zeng, Y., Zhou, L., Wang, M., Wang, J., Liu, M., & Wei, H. (2026). Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s634276
Vancouver
Luo K, Hui Y, Shen H, Yan L, Zeng Y, Zhou L, et al. Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s634276
BibTeX
@article{Luo2026,
author = {Luo, Kunpeng and Hui, Yan and Shen, Heng and Yan, Lin and Zeng, Yu and Zhou, Luyao and Wang, Min and Wang, Jianxiang and Liu, Mingcheng and Wei, Hui},
title = {Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence},
journal = {International Journal of Nanomedicine},
year = {2026},
doi = {10.2147/ijn.s634276}
}
EUVIMED